Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12INCYTE CORP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3571

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3568

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank

03

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3569

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank

04

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3569

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank

05

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3570

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank

06

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3569

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank

07

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3570

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank

08

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3571

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank

09

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3568

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank

10

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

PEMIGATINIB

US Patent Number : 11628162

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3568

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-30

blank